NCT00925314 - A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2014

Conditions

Stage IIIB Skin MelanomaStage IIIC Skin Melanoma

Interventions

BIOLOGICAL

CB-10-01 (Transgenic Lymphocyte Immunization)

1 Primary Infusion and 2 Booster Infusions

Trial Locations (5)

University of California Los Angeles, Los Angeles

John Wayne Cancer Institute, Santa Monica

City of Hope, Duarte

University of California San Diego, San Diego

Northern California Melanoma Center, San Francisco